These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6705934)

  • 1. Absence of antibodies to ethinyl estradiol in users of oral contraceptive steroids.
    Huang NH; Li C; Goldzieher JW
    Fertil Steril; 1984 Apr; 41(4):587-92. PubMed ID: 6705934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Monoclonal human immunoglobulin (IgG lambda) with antiethinylestradiol activity, oral contraceptives, and arterial pulmonary thrombosis].
    Beaumont JL; Lemort N
    C R Acad Hebd Seances Acad Sci D; 1975 Jun; 280(24):2805-8. PubMed ID: 808320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptive, pulmonary artery thrombosis and anti-ethinyl-oestradiol monoclonal IgG.
    Beaumont JL; Lemort N
    Clin Exp Immunol; 1976 Jun; 24(3):455-63. PubMed ID: 820501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiethinyloestradiol antibody activities in oral contraceptive users.
    Beaumont JL; Lemort N; Lorenzelli-Edouard L; Delplanque B; Beaumont V
    Clin Exp Immunol; 1979 Dec; 38(3):445-52. PubMed ID: 535183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethinylestradiol and diethylstilbestrol induced antibodies and vascular thrombosis.
    Beaumont V; Lemort N; Abbou CC; Beaumont JL
    Biomedicine; 1980 Feb; 32(1):26-31. PubMed ID: 7370379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of pill-induced antiethinylestradiol antibodies (author's transl)].
    Beaumont JL; Lemort N; Beaumont V; Edouard L
    Ann Biol Clin (Paris); 1981; 39(2):69-74. PubMed ID: 7258749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vascular thrombosis in synthetic estrogen-progestogen users: an immune mechanism (author's transl)].
    Beaumont V; Beaumont JL
    Nouv Presse Med; 1981 Feb; 10(7):503-7. PubMed ID: 7232196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contraceptive hormones, vascular risk and abnormal precipitation of serum gamma-globulins (author's transl)].
    Beaumont V; Lemort N; Lorenzelli L; Mosser A; Beaumont JL
    Pathol Biol (Paris); 1978 Dec; 26(9-10):531-7. PubMed ID: 85291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of antisteroid antibodies in oral contraceptive users presenting with vascular events.
    van den Brûle FA; Hendrick JC; Nervo P; Gaspard UJ
    Contraception; 1995 Oct; 52(4):237-40. PubMed ID: 8605782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisteroid immune complexes and vascular thrombosis during steroid hormone therapy.
    van den Brûle FA; Coibion M; Hendrick JC; Gaspard UJ
    Contraception; 1994 Jun; 49(6):571-7. PubMed ID: 8070262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of switching with oral contraceptives.
    Wassef SA; Sami G; Hamid EA
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):77-93. PubMed ID: 12254511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Contraceptive hormones, vascular risk and abnormal precipitation of serum gamma-globulins (author's transl)].
    Beaumont V; Lemort N; Lorenzelli L; Mosser A; Beaumont JL
    Sem Hop; 1979 Mar 18-25; 55(1112):585-91. PubMed ID: 89695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral contraception, circulating immune complexes, antiethinylestradiol antibodies, and thrombosis.
    Beaumont V; Lemort N; Beaumont JL
    Am J Reprod Immunol (1980); 1982 Feb; 2(1):8-12. PubMed ID: 7091494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of risk factors associated with vascular thrombosis in women on oral contraceptives. Possible role of anti-sex steroid hormone antibodies.
    Beaumont V; Lemort N; Beaumont JL
    Artery; 1983; 11(5):331-44. PubMed ID: 6661039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogens: why harmless as menopausal therapy but hazardous in the "Pill"?
    Edwards CC; Drill VA
    JAMA; 1971 Jan; 215(3):(3): 492-493. PubMed ID: 12332746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the combined steroidal contraceptives (Gynanovlar 21 and Lyndiol 2.5) on the human adrenocortical and ovarian activities.
    Zaki K; Kamal I; Talaat MM; Rashad S; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):41-65. PubMed ID: 12256027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contraceptive hormones, vascular risk, and abnormal precipitation of serum gamma-globulins.
    Beaumont V; Lemort N; Lorenzelli L; Mosser AM; Beaumont JL
    Sem Hop Paris; 1979 Mar 18-25; 55(11-12):5850591. PubMed ID: 12278180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vascular complications of oral contraception. In whom and how to prevent them?].
    Beaumont V; Lemort N; Beaumont JL
    Presse Med; 1983 Dec; 12(47):2977-81. PubMed ID: 6228887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
    Kamal I; Zaki K; Rashad S
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.